These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 25841143)

  • 1. Contribution of ultrasound contrast in predicting conduction disturbances during percutaneous alcohol septal ablation.
    Ternacle J; Boiron P; Gallet R; Champagne S; Krapf L; Doan HL; Randé JL; Teiger E; Lim P
    Int J Cardiol; 2015; 187():436-7. PubMed ID: 25841143
    [No Abstract]   [Full Text] [Related]  

  • 2. Three-dimensional contrast echocardiography-guided alcohol septal ablation in hypertrophic obstructive cardiomyopathy.
    Moya Mur JL; Salido Tahoces L; Mestre Barcelo JL; Fernandez Golfín C; Zamorano Gómez JL
    Eur Heart J Cardiovasc Imaging; 2014 Feb; 15(2):226. PubMed ID: 23988326
    [No Abstract]   [Full Text] [Related]  

  • 3. Atrioventricular conduction after alcohol septal ablation for obstructive hypertrophic cardiomyopathy.
    Axelsson A; Weibring K; Havndrup O; Kelbæk H; Jørgensen E; Helqvist S; Iversen K; Køber L; Bundgaard H; Jensen MK
    J Cardiovasc Med (Hagerstown); 2014 Mar; 15(3):214-21. PubMed ID: 24662414
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low incidence of procedure-related major adverse cardiac events after alcohol septal ablation for symptomatic hypertrophic obstructive cardiomyopathy.
    Veselka J; Lawrenz T; Stellbrink C; Zemanek D; Branny M; Januska J; Groch L; Dimitrow P; Krejci J; Dabrowski M; Mizera S; Kuhn H
    Can J Cardiol; 2013 Nov; 29(11):1415-21. PubMed ID: 23927866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alcohol septal ablation for the treatment of hypertrophic obstructive cardiomyopathy. A multicenter North American registry.
    Nagueh SF; Groves BM; Schwartz L; Smith KM; Wang A; Bach RG; Nielsen C; Leya F; Buergler JM; Rowe SK; Woo A; Maldonado YM; Spencer WH
    J Am Coll Cardiol; 2011 Nov; 58(22):2322-8. PubMed ID: 22093510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alcohol septal ablation in a patient with hypertrophic obstructive cardiomyopathy.
    Agarwal S; Puri S; Wang H
    J Cardiothorac Vasc Anesth; 2014 Apr; 28(2):350-4. PubMed ID: 23992655
    [No Abstract]   [Full Text] [Related]  

  • 7. Predictors of complete heart block after alcohol septal ablation for hypertrophic cardiomyopathy and the timing of pacemaker implantation.
    El-Jack SS; Nasif M; Blake JW; Dixon SR; Grines CL; O'Neill WW
    J Interv Cardiol; 2007 Feb; 20(1):73-6. PubMed ID: 17300408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Alcohol septal ablation in hypertrophic cardiomyopathy: an opportunity to be taken.
    Gimeno JR; Tomé MT; McKenna WJ
    Rev Esp Cardiol (Engl Ed); 2012 Apr; 65(4):314-8. PubMed ID: 22381943
    [No Abstract]   [Full Text] [Related]  

  • 9. Serial septal branch assessment in hypertrophic obstructive cardiomyopathy: New echocardiographic contrast agent for alcohol septal ablation.
    Rigopoulos AG; Pfeiffer B; Seggewiss H
    Herz; 2014 Mar; 39(2):219-21. PubMed ID: 23588605
    [No Abstract]   [Full Text] [Related]  

  • 10. Delayed reversibility of complete atrioventricular block: cardio-biliary reflex after alcohol septal ablation in a patient with hypertrophic obstructive cardiomyopathy.
    Fang S; Gao L; Yang F; Gong YJ
    BMC Cardiovasc Disord; 2021 Aug; 21(1):372. PubMed ID: 34344308
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Percutaneous septal ablation for symptomatic hypertrophic obstructive cardiomyopathy: managing the risk of procedure-related AV conduction disturbances.
    Faber L; Welge D; Fassbender D; Schmidt HK; Horstkotte D; Seggewiss H
    Int J Cardiol; 2007 Jul; 119(2):163-7. PubMed ID: 17067708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alcohol septal ablation in hypertrophic obstructive cardiomyopathy.
    Rigopoulos AG; Panou F; Kremastinos DT; Seggewiss H
    Hellenic J Cardiol; 2009; 50(6):511-22. PubMed ID: 19942565
    [No Abstract]   [Full Text] [Related]  

  • 13. [Predicting the risk of atrioventricular conduction lesions after percutaneous septal ablation for obstructive hypertrophic cardiomyopathy].
    Faber L; Seggewiss H; Welge D; Fassbender D; Ziemssen P; Schmidt HK; Gleichmann U; Horstkotte D
    Z Kardiol; 2003 Jan; 92(1):39-47. PubMed ID: 12545300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alcohol Ablation in Hypertrophic Cardiomyopathy: Localization and Quantification of Target Septal Artery-dependent Myocardium With 3-Dimensional Echocardiography.
    Moya-Mur JL; Mestre-Barcelo JL; Salido-Tahoces L; Hinojar-Baydes R; Hernández-Antolín R; Zamorano-Gómez JL
    Rev Esp Cardiol (Engl Ed); 2015 Jun; 68(6):531-3. PubMed ID: 25935148
    [No Abstract]   [Full Text] [Related]  

  • 15. Alcohol septal ablation versus surgical septal myectomy: comparison of effects on atrioventricular conduction tissue.
    Talreja DR; Nishimura RA; Edwards WD; Valeti US; Ommen SR; Tajik AJ; Dearani JA; Schaff HV; Holmes DR
    J Am Coll Cardiol; 2004 Dec; 44(12):2329-32. PubMed ID: 15607394
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coronary morphology and conduction system disturbance induced by therapeutic embolization of the coronary septal artery.
    Gomes OM; Coelho AA; Osterne EC; Abrantes RD
    Heart Surg Forum; 2010 Feb; 13(1):E45-8. PubMed ID: 20150040
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of varying ethanol dosing in percutaneous septal ablation for obstructive hypertrophic cardiomyopathy on early hemodynamic changes.
    Veselka J; Duchonová R; Procházková S; Pálenícková J; Sorajja P; Tesar D
    Am J Cardiol; 2005 Mar; 95(5):675-8. PubMed ID: 15721120
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Myocardial contrast echocardiography guided alcohol septal ablation in hypertrophic obstructive cardiomyopathy with a new echocardiographic contrast agent].
    Pfeiffer B; Rigopoulos A; Seggewiß H
    Dtsch Med Wochenschr; 2012 Oct; 137(41):2093-6. PubMed ID: 23033167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alcohol septal ablation for hypertrophic obstructive cardiomyopathy, the first cases series in Thailand.
    Chamnarnphol N; Wisaratapong T
    J Med Assoc Thai; 2008 Dec; 91(12):1801-5. PubMed ID: 19133512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intraprocedural myocardial contrast echocardiography as a routine procedure in percutaneous transluminal septal myocardial ablation: detection of threatening myocardial necrosis distant from the septal target area.
    Faber L; Seggewiss H; Ziemssen P; Gleichmann U
    Catheter Cardiovasc Interv; 1999 Aug; 47(4):462-6. PubMed ID: 10470478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.